Cargando…
Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is general...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747542/ https://www.ncbi.nlm.nih.gov/pubmed/12569381 http://dx.doi.org/10.1038/sj.bjc.6600736 |
_version_ | 1782172104567816192 |
---|---|
author | Vivo, C Lecomte, C Levy, F Leroy, K Kirova, Y Renier, A Kheuang, L Piedbois, P Chopin, D Jaurand, M C |
author_facet | Vivo, C Lecomte, C Levy, F Leroy, K Kirova, Y Renier, A Kheuang, L Piedbois, P Chopin, D Jaurand, M C |
author_sort | Vivo, C |
collection | PubMed |
description | Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is generally not mutated, but may be inactivated by SV40 early region T antigen (SV40 Tag). However, the function of p53 has not been investigated in mesothelioma cells. Here, we investigated the function of the cell cycle checkpoints in six human mesothelioma cell lines (HMCLs) by studying the cell distribution in the different phases of the cell cycle by flow cytometry, and expression of cell cycle proteins, p53, p21(WAF1/CIP1) and p27(KIP1). In addition, we studied p53 gene mutations and expression of SV40 Tag. After exposure to γ-radiation, HMCLs were arrested either in one or both phases of the cell cycle, demonstrating a heterogeneity in cell cycle control. G1 arrest was p21(WAF1/CIP1)- and p53-dependent. Lack of arrest in G1 was not related to p53 mutation or binding to SV40 Tag, except in one HMCL presenting a missense mutation at codon 248. These results may help us to understand mesothelioma and develop new treatments. |
format | Text |
id | pubmed-2747542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-27475422009-09-21 Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation Vivo, C Lecomte, C Levy, F Leroy, K Kirova, Y Renier, A Kheuang, L Piedbois, P Chopin, D Jaurand, M C Br J Cancer Molecular and Cellular Pathology Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is generally not mutated, but may be inactivated by SV40 early region T antigen (SV40 Tag). However, the function of p53 has not been investigated in mesothelioma cells. Here, we investigated the function of the cell cycle checkpoints in six human mesothelioma cell lines (HMCLs) by studying the cell distribution in the different phases of the cell cycle by flow cytometry, and expression of cell cycle proteins, p53, p21(WAF1/CIP1) and p27(KIP1). In addition, we studied p53 gene mutations and expression of SV40 Tag. After exposure to γ-radiation, HMCLs were arrested either in one or both phases of the cell cycle, demonstrating a heterogeneity in cell cycle control. G1 arrest was p21(WAF1/CIP1)- and p53-dependent. Lack of arrest in G1 was not related to p53 mutation or binding to SV40 Tag, except in one HMCL presenting a missense mutation at codon 248. These results may help us to understand mesothelioma and develop new treatments. Nature Publishing Group 2003-02-10 2003-02-10 /pmc/articles/PMC2747542/ /pubmed/12569381 http://dx.doi.org/10.1038/sj.bjc.6600736 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Molecular and Cellular Pathology Vivo, C Lecomte, C Levy, F Leroy, K Kirova, Y Renier, A Kheuang, L Piedbois, P Chopin, D Jaurand, M C Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
title | Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
title_full | Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
title_fullStr | Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
title_full_unstemmed | Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
title_short | Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
title_sort | cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation |
topic | Molecular and Cellular Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747542/ https://www.ncbi.nlm.nih.gov/pubmed/12569381 http://dx.doi.org/10.1038/sj.bjc.6600736 |
work_keys_str_mv | AT vivoc cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT lecomtec cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT levyf cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT leroyk cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT kirovay cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT reniera cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT kheuangl cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT piedboisp cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT chopind cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation AT jaurandmc cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation |